Vyloy (zolbetuximab-clzb) - Astellas
Obstructive Jaundice Mimicking Pancreatobiliary Malignancy: A Rare Presentation of Claudin 18.2âPositive Poorly Cohesive Gastric Adenocarcinoma (ACG 2026) - Aug 29, 2026 - Abstract #P2199; Pres time: Oct 11, 2026; 03:30 PM - 07:00 PM; Location: Exhibit Halls A - D (Level 3); "CLDN18.2 positivity (~90%) identifies this patient as a candidate for zolbetuximab-based therapy. Gastric cancer should be recognized as a rare cause of multi-level biliary obstruction." 
IO biomarker • Biliary Cancer • Biliary Tract Cancer • Cholangiocarcinoma • Gastric Adenocarcinoma • Gastric Cancer • Gastrointestinal Disorder • Hepatology • Oncology • Pruritus • Solid Tumor • CLDN18 • HER-2 • PD-L1
https://acg2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=R01PT1FGR0UyNjkyNQ&PosterID=832330&rnd=0.8011262
 
Diana Moni Febles MD 1; Rafael Arzuaga Rodriguez MD 2; Maria Maysonet Pastrana MS 2; David Vera Santiago MD 2; Javier A. A. Cerra Franco MD 3
 
Aug 29, 2026
 
Prev Next